Alison Reid MD, PhD

Dr. Alison Reid is a Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust. She specializes in the treatment of prostate and testicular cancers.

She joined the Royal Marsden in 2005 and worked in early Phase clinical trials before pursuing a Ph.D. in castration-resistant prostate cancer (CRPC) at The Institute of Cancer Research. During her Ph.D., she published widely on the early clinical development of abiraterone acetate for prostate cancer and in the implementation of molecular studies for patient stratification.

For her research, Dr. Reid received awards from the American Society of Clinical Oncology, the European Society of Medical Oncology, and the American Association for Cancer Research. Dr. Reid was appointed to a medical oncology consultant position in 2014.

She leads the prostate medical oncology service in RM Sutton and Kingston and serves as a principal investigator on therapeutic trials for prostate cancer. She is also committed to testicular cancer research focusing on understanding the mechanisms of treatment resistance and survivorship endeavors.

She is a member of the EORTC genitourinary group, the NCRI teenage young adult and germ cell tumors clinical studies group, and the RM partners Urology Pathway Group.